Iza-bren included in 2026 national medical insurance drug catalog
Briefing by News4U · First published
On November 14, 2026, the 2026 national medical insurance drug catalog was officially released at the 2026 National High-Quality Development Conference on Innovative Drugs. Baili Tianheng's iza-bren, the world's first and only approved EGFR×HER3 bispecific ADC drug, was successfully included in the 2026 National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog through national medical insurance negotiations. Thanks to the first-time implementation of the medical insurance pre-declaration mechanism this year, iza-bren achieved inclusion in the medical insurance in its first year on the market. The new national medical insurance catalog will be officially implemented starting January 1, 2027. [1] [2]
Sources
- 伦康依隆妥单抗进入国家医保药品目录，将减轻鼻咽癌患者负担
The Paper · · Full text
- 快讯
Wall Street CN · · Full text